Overdiagnosis in Melanoma Screening: Is it a Real Problem?

Overdiagnosis in Melanoma Screening: Is it a Real Problem?

Authors

  • Brigid Betz-Stablein Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia
  • H. Peter Soyer Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia

Keywords:

underdiagnosis, melanoma incidence, biopsy rates, total body photography, dermoscopy

References

Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-13.

Semsarian CR, Ma T, Nickel B, Scolyer RA, Ferguson PM, Soyer HP, et al. Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Br J Dermatol. 2022;186(6):1030-2.

Harms PW, Chan MP, Bresler SC, Andea AA, Hristov AC, Fullen DR, et al. Comment on "An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017". J Invest Dermatol. 2022;142(11):3120-2.

Kurtansky NR, Dusza SW, Halpern AC, Hartman RI, Geller AC, Marghoob AA, et al. An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017. J Invest Dermatol. 2022;142(7):1804-11 e6.

Welch HG, Mazer BL, Adamson AS. The Rapid Rise in Cutaneous Melanoma Diagnoses. N Engl J Med. 2021;384(1):72-9.

Pathirana T, Clark J, Moynihan R. Mapping the drivers of overdiagnosis to potential solutions. BMJ (Clinical research ed). 2017;358:j3879.

Olsen CM, Pandeya N, Rosenberg PS, Whiteman DC. Incidence of in Situ vs Invasive Melanoma: Testing the "Obligate Precursor" Hypothesis. J Natl Cancer Inst. 2022;114(10):1364-70.

Whiteman DC, Olsen CM, MacGregor S, Law MH, Thompson B, Dusingize JC, et al. The effect of screening on melanoma incidence and biopsy rates. Br J Dermatol. 2022;187(4):515-22.

Piepkorn MW, Eguchi MM, Barnhill RL, Elder DE, Kerr KF, Knezevich SR, et al. Reproducibility of the histopathologic diagnosis of melanoma and related melanocytic lesions: Results from a testing study and a reference guide for providers. JAAD Int. 2022;9:7-10.

Moloney FJ, Guitera P, Coates E, Haass NK, Ho K, Khoury R, et al. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol. 2014;150(8):819-27.

Tschandl P, Rinner C, Apalla Z, Argenziano G, Codella N, Halpern A, et al. Human-computer collaboration for skin cancer recognition. Nat Med. 2020;26(8):1229-34.

Primiero CA, McInerney-Leo AM, Betz-Stablein B, Whiteman DC, Gordon L, Caffery L, et al. Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial. BMJ Open. 2019;9(11):e032969.

Daneshjou R, Barata C, Betz-Stablein B, Celebi ME, Codella N, Combalia M, et al. Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology: CLEAR Derm Consensus Guidelines From the International Skin Imaging Collaboration Artificial Intelligence Working Group. JAMA Dermatol. 2022;158(1):90-6.

Grant SR, Andrew TW, Alvarez EV, Huss WJ, Paragh G. Diagnostic and Prognostic Deep Learning Applications for Histological Assessment of Cutaneous Melanoma. Cancers (Basel). 2022;14(24).

Downloads

Published

2023-10-31

Issue

Section

Kramer vs Kramer

How to Cite

1.
Overdiagnosis in Melanoma Screening: Is it a Real Problem?. Dermatol Pract Concept [Internet]. 2023 Oct. 31 [cited 2024 Jul. 13];13(4):e2023247. Available from: https://dpcj.org/index.php/dpc/article/view/3748

Share